Breaking News
June 23, 2018 - Apps for children should emphasize parent and child choice, researchers say
June 23, 2018 - Teenage girls report higher degree of daytime sleepiness than boys
June 23, 2018 - Protein Data Bank at Rutgers impacts research, education and drug discovery
June 23, 2018 - Study unravels new piece of information in the Huntington’s disease puzzle
June 23, 2018 - Scientists develop new device to test cancer drug combinations quickly and cheaply
June 23, 2018 - Neural Analytics wins CE Mark for NeuralBot System
June 23, 2018 - Infant omega-3 supplementation tied to decreased waist size
June 23, 2018 - Massive analysis of genomes reveals insights into genetic overlap among psychiatric diseases
June 23, 2018 - New therapeutic approach may delay neurodegeneration in rare genetic disease
June 23, 2018 - Broken shuttle protein may hinder learning in patients with brain disorders
June 23, 2018 - Study finds increase in daily cannabis use among American adults
June 23, 2018 - Researchers create electronic skin that brings back real sense of touch to prosthetic limbs
June 23, 2018 - FIRS: Guidance Offered for Protecting Youth From E-Cigarettes
June 23, 2018 - Scientists unravel molecular mechanisms of Parkinson’s disease
June 23, 2018 - When the Heart Stops, Drugs Often to Blame
June 23, 2018 - Scientists show that a key Parkinson’s biomarker can be identified in the retina
June 23, 2018 - Study finds factors underlying current rise in radicalization among European youth
June 23, 2018 - New study finds higher heart disease risk in bisexual men
June 23, 2018 - Coconut oil diet increases vitality, lifespan of fruit flies with peroxisomal disorder
June 23, 2018 - Jumping genes or transposons and their role in the genetic code
June 23, 2018 - The Current issue of “The view from here” is concerned with Therapeutics
June 23, 2018 - Abnormal lipid metabolism in fat cells predicts future weight gain and diabetes in women
June 23, 2018 - Alcohol problems linked to sex without condom use among black gay men
June 23, 2018 - DNA patterns in circulating blood cells can help identify spastic cerebral palsy
June 23, 2018 - Unsubstantiated health claims widespread within weight loss industry
June 23, 2018 - FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients
June 23, 2018 - An ingrown toenail not the same as a bypass
June 23, 2018 - Study suggests proteinuria lowering as important target in managing pediatric CKD
June 23, 2018 - Research consortium wins £2.9 million to help tackle antibacterial resistance in Thailand
June 23, 2018 - Schizophrenia patients account for over 1 in 10 suicide deaths, study shows
June 23, 2018 - Overdose risk increases five-fold with concurrent opioid and benzodiazepine use
June 23, 2018 - FDA Alert: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall
June 23, 2018 - Study highlights inadequate effort of health care insurers to combat opioid epidemic
June 23, 2018 - CDC chief asks for, and gets, cut to his record $375K pay
June 22, 2018 - Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis
June 22, 2018 - Pioneering exercise program improves physical, mental health of elderly people living in care homes
June 22, 2018 - Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment
June 22, 2018 - Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors
June 22, 2018 - Study links annual haze with increased hospitalizations for respiratory problems
June 22, 2018 - Robotic surgery appears to be as effective as open surgery in treating bladder cancer
June 22, 2018 - Many Drugs Made Available Via FDA Expanded Access Programs
June 22, 2018 - Normal eye dominance is not necessary for restoring visual acuity in amblyopia
June 22, 2018 - Parent-Child Interaction Therapy can reduce depression rates in children
June 22, 2018 - Study provides insights into how components of different cells in the brain are altered
June 22, 2018 - Research does not confirm antidiabetic action of natural fatty acid derivatives
June 22, 2018 - Oxidative stress can be used against tumors to treat cancer
June 22, 2018 - Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment
June 22, 2018 - New guide published to help battle fatal disease caused by kissing bugs
June 22, 2018 - Stigma Adds to Burden of Type 1 Diabetes
June 22, 2018 - In retinoblastoma survivors, oculo-visual issues tied to QoL
June 22, 2018 - Most adults with allergies do not use prescribed epinephrine even in emergency situations
June 22, 2018 - Study provides clues to how cancer cells develop resistance to chemotherapies
June 22, 2018 - New consensus paper serves as basis for uniform medical management of DSD
June 22, 2018 - Researchers work to identify areas of the brain that help us wake up
June 22, 2018 - Alcohol hangovers more significant and costly than people realize, shows research
June 22, 2018 - Targeting cells involved in blood vessel formation could hinder brain tumor growth
June 22, 2018 - Young cancer survivors need more support as they feel dissatisfied with their sexuality
June 22, 2018 - Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance
June 22, 2018 - Turning A Phage – Drug Discovery Today
June 22, 2018 - World-first study links birth interventions and long-term childhood illness
June 22, 2018 - Improving the quality of biomedical research samples
June 22, 2018 - Researchers identify cerebral palsy using AI and DNA sequencing
June 22, 2018 - Administering nitric oxide gas after heart surgery may decrease risk of kidney problems
June 22, 2018 - Measuring levels of ethyl sulphate in hair can help assess alcohol consumption
June 22, 2018 - Researchers develop robot bloodhound that can rapidly detect odors on the ground
June 22, 2018 - AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer
June 22, 2018 - LSTM led consortium receives grant to investigate how human behavior impacts AMR
June 22, 2018 - Researchers discover drug compound that inhibits movement of cancer cells
June 22, 2018 - Normalization of ‘plus-size’ body shapes may prevent recognition of health risks of obesity
June 22, 2018 - UC San Diego launches new bacteriophage therapy center
June 22, 2018 - New review outlines current state of sex-sensitive issues linked to heart failure drugs
June 22, 2018 - Pelvic pain a major issue for women nearing mid-life, research reveals
June 22, 2018 - Researchers develop reliable DNA barcodes for biomedical research
June 22, 2018 - New risk-prediction model may help identify diabetic patients at high risk of pancreatic cancer
June 22, 2018 - Study reveals how mTORC1-driven changes in crowding could influence major diseases
June 22, 2018 - Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma
June 22, 2018 - UC Riverside researcher receives grants to advance cancer, ALS research
June 22, 2018 - Radiation therapy alone may be enough to treat older, sicker patients with anal cancers
June 22, 2018 - Technical report describes how to make accurate particle size measurements on carbon black samples
June 22, 2018 - Nocdurna (desmopressin acetate) Approved by FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
Single PSA Test Fails to Reduce Prostate Ca Deaths

Single PSA Test Fails to Reduce Prostate Ca Deaths

image_pdfDownload PDFimage_print

Action Points

  • One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, according to results of a randomized trial including over 400,000 British men in 573 primary care practices.
  • Recognize that screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment.

One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, despite an uptick in diagnoses of the disease, according to results of a randomized trial that included over 400,000 British men.

During the trial, 549 of 189,386 patients in the screening arm died from prostate cancer (0.30 per 1,000 person-years) compared with 647 of 219,439 patients in the control arm (0.31 per 1,000 person-years) for a rate ratio of 0.96 (P=0.50).

“The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) was designed to determine the effects of a low-intensity, single invitation PSA test,” wrote Richard M. Martin, PhD, of the University of Bristol, England, in JAMA. “Although longer-term follow-up is under way, the findings do not support single PSA testing for population-based screening.”

The trial included 419,582 men ages 50 to 69 screened at 573 primary care practices across the United Kingdom. Patients were recruited beginning in 2001, with follow-up concluding in 2016.

While no reduction in deaths due to prostate cancer were seen among screened patients, more cases of the disease were diagnosed in men receiving a PSA test (4.3%) compared with unscreened patients (3.6%). More tumors with a Gleason score of 6 or lower were identified in the screened group compared with the control group (1.7% versus 1.1%, respectively).

Localized disease (stage T1 or T2 cancer) was diagnosed at a more frequent rate in the screened group (2.6% versus 1.9% in the control group); in turn, fewer cases of advanced-stage cancer were diagnosed in this group (0.5% versus 0.6% in the control group).

Of the 549 men who died of prostate cancer in the screening group, only 188 had visited the clinic for PSA testing. Lethal cancer was diagnosed in 59 of these 188. Of the remaining 129 patients:

  • 68 were ineligible for prostate biopsy due to a PSA level less than 3.0 ng/mL,
  • 42 did not undergo PSA testing despite having attended the clinic,
  • 15 men had a PSA level 3.0 ng/mL or higher yet did not undergo a biopsy,
  • and 4 men had a benign biopsy.

In the all-cause mortality analysis, 25,459 died in the intervention group compared with 28,306 in the control group for a RR of 0.99 (P=0.49).

Screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment. In 2012, the U.S. Preventive Services Task Force (USPSTF) recommended against routine PSA screening for men of any age, but in 2017 adjusted this recommendation and now support an individualized approach to screening for men ages 55 to 69.

“It has been hypothesized that screening men in their early 50s may be more effective than at a later age,” the authors wrote. “However, we did not find statistical evidence to support this.”

In terms of adherence to screening, 75,707 patients (40%) of the 189,386 men assigned to the intervention arm attended the clinic for PSA testing; 67,313 of these men underwent PSA testing. High PSA levels — 3.0 ng/mL to 19.9 ng/mL — were detected in 6,857 patients and 5,850 underwent a biopsy.

In an editorial accompanying the article, Michael J. Barry, MD, of Harvard Medical School and Massachusetts General Hospital in Boston, wrote: “A key question is whether the findings from the CAP trial should swing the pendulum further in the direction of not offering screening PSA tests. Based on the CAP results, an offer of a single PSA screen in a population of men aged 50 to 69 years is ineffective, and given the higher risk of a prostate cancer diagnosis this approach engenders, likely does more harm than good.”

Barry, who is a member of the USPSTF, added that while further follow-up from CAP could potentially reveal benefit, based on the evidence so far “that eventuality seems unlikely.”

Martin and co-authors reported no conflicts of interest. Barry is chief science officer at Healthwise, and grants from the company have been awarded to Massachusetts General Hospital.

The CAP trial was funded by grants from Cancer Research U.K., and partial funding was provided by the U.K. Department of Health, National Institute of Health Research.

2018-06-03T00:00:00-0400

last updated

Tagged with:

About author

Related Articles